Morgan Stanley’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.5M | Sell |
|
|||||
|
2025
Q1 | $27.7M | Sell |
|
|||||
|
2024
Q4 | $26.3M | Buy |
|
|||||
|
2024
Q3 | $23.7M | Buy |
|
|||||
|
2024
Q2 | $11.7M | Sell |
|
|||||
|
2024
Q1 | $21.4M | Sell |
|
|||||
|
2023
Q4 | $41.9M | Buy |
|
|||||
|
2023
Q3 | $7.54M | Buy |
|
|||||
|
2023
Q2 | $4.98M | Buy |
|
|||||
|
2023
Q1 | $660K | Sell |
|
|||||
|
2022
Q4 | $907K | Sell |
|
|||||
|
2022
Q3 | $1.06M | Sell |
|
|||||
|
2022
Q2 | $2.47M | Buy |
|
|||||
|
2022
Q1 | $3.4M | Buy |
|
|||||
|
2021
Q4 | $2.3M | Sell |
|
|||||
|
2021
Q3 | $3.86M | Sell |
|
|||||
|
2021
Q2 | $6.09M | Buy |
|
|||||
|
2021
Q1 | $4.73M | Sell |
|
|||||
|
2020
Q4 | $18.3M | Buy |
|
|||||
|
2020
Q3 | $6.95M | Buy |
|
|||||
|
2020
Q2 | $2.49M | Sell |
|
|||||
|
2020
Q1 | $3.92M | Buy |
|
|||||
|
2019
Q4 | $2.37M | Buy |
|
|||||
|
2019
Q3 | $154K | Sell |
|
|||||
|
2019
Q2 | $344K | Sell |
|
|||||
|
2019
Q1 | $4.83M | Sell |
|
|||||
|
2018
Q4 | $6.49M | Buy |
|
|||||
|
2018
Q3 | $8.7M | Buy |
|
|||||
|
2018
Q2 | $4.1M | Buy |
|
|||||
|
2018
Q1 | $2.48M | Buy |
|
|||||
|
2017
Q4 | $1.2M | Buy |
|
|||||
|
2017
Q3 | $456K | Sell |
|
|||||
|
2017
Q2 | $563K | Sell |
|
|||||
|
2017
Q1 | $994K | Sell |
|
|||||
|
2016
Q4 | $1.64M | Buy |
|
|||||
|
2016
Q3 | $181K | Sell |
|
|||||
|
2016
Q2 | $122K | Sell |
|
|||||
|
2016
Q1 | $234K | Sell |
|
|||||
|
2015
Q4 | $690K | Buy |
|
|||||
|
2015
Q3 | $344K | Sell |
|
|||||
|
2015
Q2 | $573K | Buy |
|
|||||
|
2015
Q1 | $288K | Sell |
|
|||||
|
2014
Q4 | $275K | Sell |
|
|||||
|
2014
Q3 | $313K | Sell |
|
|||||
|
2014
Q2 | $5.34M | Sell |
|
|||||
|
2014
Q1 | $5.88M | Sell |
|
|||||
|
2013
Q4 | $4.51M | Buy |
|
|||||
|
2013
Q3 | $4.94M | Buy |
|
|||||
|
2013
Q2 | $118K | Buy |
|